Amgen Inc. buy phonebroker
Start price
26.03.16
/
50%
€135.16
Target price
17.06.16
€171.27
Performance (%)
0.71%
End price
17.06.16
€135.22
Summary
This prediction ended on 17.06.16 with a price of €135.22. The BUY prediction by phonebroker for Amgen Inc. closed nearly unchanged. phonebroker has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Amgen Inc. | -4.430% | -4.430% | 3.419% | 3.064% |
| iShares Core DAX® | 0.734% | -0.964% | 17.910% | 65.510% |
| iShares Nasdaq 100 | -2.686% | -2.409% | 4.267% | 95.368% |
| iShares Nikkei 225® | -2.261% | -4.038% | 10.420% | 42.232% |
| iShares S&P 500 | -1.346% | -1.510% | 1.615% | 59.132% |
Comments by phonebroker for this prediction
In the thread Amgen Inc. diskutieren
phonebroker stimmt dem Sentiment von 'Buy' zu
phonebroker stimmt am 26.03.2016 dem Buy-Gesamtsentiment mit dem Kursziel 189.88$ zu. Der BioTech-Sektor ist in letzter Zeit nicht so gut gelaufen. Das könnte sich in nächster Zeit wieder ändern.
(Stop Loss Kurs erreicht)